SAN DIEGO, Oct. 21 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical company, announced today that Joseph M. Limber, President and Chief Executive Officer, will present a company overview at the annual C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference. The presentation is scheduled for 8:00 a.m. Eastern Time, Tuesday, October 25, 2005 at the New York Palace Hotel.
The presentation will be open to interested parties through a live web cast at Prometheus’ website, www.prometheuslabs.com. The presentation will be archived on the Company’s website for 30 days.
Prometheus Laboratories Inc. is a specialty pharmaceutical company committed to developing new ways to help physicians individualize patient care. Prometheus focuses on the treatment, diagnosis and detection of gastrointestinal, autoimmune and inflammatory diseases and disorders. Prometheus’ strategy includes the marketing and delivery of pharmaceutical products complemented by its proprietary, high-value diagnostic testing services. By integrating therapeutics and diagnostic services, Prometheus addresses the continuum of patient care, thereby providing physicians with a comprehensive solution to treat chronic diseases. Prometheus’ corporate offices are located in San Diego, California. Additional information about Prometheus can be found at www.prometheuslabs.com.
Prometheus Laboratories Inc.
CONTACT: Beth Kriegel, Senior Director, Financial Planning and InvestorRelations of Prometheus Laboratories Inc., +1-858-410-2516
Web site: http://www.prometheuslabs.com/
